⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 9, 2015JAMA OncologyOpen Access

Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma

Ya Ruth Huo Guy D. Eslick

View Full Paper

Ask AI

Bookmark

Share

Abstract

TACE plus RT was more therapeutically beneficial than TACE alone for treating HCC, and should be recommended for suitable patients with unresectable HCC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Huo et al. (2015) studied this question.

synapsesocial.com/papers/69d739ebef4aa71f97f308d8 https://doi.org/10.1001/jamaoncol.2015.2189

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast CancerJAMA Oncology · Thu,
2“Low-Risk” Ovarian Lesions—The Case for Early Follow-UpJAMA Oncology · Thu,
3Long-Term Outcomes of De-Escalated 30-Gy Elective Irradiation in HPV-Associated Oropharyngeal CancerJAMA Oncology · Thu,
4Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell CarcinomaJAMA Oncology · Thu,
5Nivolumab-Ipilimumab for Localized Microsatellite Instability–High Gastric/Gastroesophageal Junction AdenocarcinomaJAMA Oncology · Thu,

More from JAMA Oncology

Beyond Tumor Size, Toward Meaningful Patient Outcomes—Resisting RECISTThu,
Disitamab Vedotin Plus Tislelizumab in Transurethrally Unresectable, ERBB2 -Positive, Non–Muscle-Invasive Bladder CancerThu,
Rethinking Treatment Intensification in Poorly Chemosensitive Ovarian CancerThu,
Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular CarcinomaThu,
Rethinking Value in Cancer Care in the USThu,